Latest Breaking News On - Otsuka pharmaceutical co ltd - Page 23 : comparemela.com

Shape, Otsuka ink $1 5B gene therapy alliance targeting ocular diseases

In its second big pharma deal to date, Shape Therapeutics Inc. drew Otsuka Pharmaceutical Co. Ltd. to the table in a potential $1.5 billion-plus collaboration initially aimed at developing gene therapies for ocular diseases. The multitarget agreement, which includes options for additional targets and tissue types, will combine Shape’s AI-driven adeno-associated virus (AAV) platform and Otsuka’s expertise in ophthalmology to develop intravitreally delivered AAV therapies.

Shape therapeutics incOtsuka pharmaceutical coShape therapeuticsOtsuka pharmaceuticalShape therapeutics incOtsuka pharmaceutical co ltdArtificial intelligenceGenerative aiOcular disease

Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases

Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Francois vigneaultCindy fungJeffrey gilbertToshiki sudoOtsuka pharmaceutical co ltdOsaka research centerDrug discoveryOtsuka pharmaceuticalMedia contact

EQS-News: AdhereTech, Inc : AdhereTech Appoints Innes Meldrum as President and Chief Executive Officer

EQS-News: AdhereTech, Inc : AdhereTech Appoints Innes Meldrum as President and Chief Executive Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNew yorkBaden wübergDaniel raynorChris obrienNeale trangucciAbilify maintenaInnes meldrumAdheretech incOtsuka pharmaceutical co ltdOtsuka pharmaceuticals north americaCapgemini consulting health prize technologiesDistribution servicesNews serviceTech appoints innes meldrumChief executive officer

EQS-News: AdhereTech Appoints Innes Meldrum as President and Chief Executive Officer

EQS-News: AdhereTech, Inc. / Key word(s): Personnel AdhereTech Appoints Innes Meldrum as President and Chief Executive Officer 06.09.2023 / 16:00 CET/CEST The issuer is solely responsible for the content of this announcement. AdhereTech Appoints Innes Meldrum as President and Chief Executive Off.

United statesNew yorkInnes meldrumAbilify maintenaNeale trangucciChris obrienDaniel raynorAdheretech incOtsuka pharmaceutical co ltdDistribution servicesNews serviceCapgemini consulting health prize technologiesOtsuka pharmaceuticals north americaTech appoints innes meldrumChief executive officerChief executive

AdhereTech Appoints Innes Meldrum as President and Chief

Brings significant experience in successfully commercializing novel products in both the pharmaceutical and technology industriesWill drive company as it.

Neale trangucciDaniel raynorAbilify maintenaInnes meldrumChris obrienAdheretech incCapgemini consulting health prize technologiesOtsuka pharmaceuticals north americaOtsuka pharmaceutical co ltdChief executiveChriso brienChief executive officerSenior vice presidentChief commercial officerOtsuka pharmaceuticals northCommercial vice president